Wednesday, March 29, 2023 | Back issues
Courthouse News Service Courthouse News Service

Prescription Drug

NEWARK - GlaxoSmithKline and Teva Pharmaceuticals conspired to restrict competition and raise prices for lamotrigine (Lamictal), a $2 billion-a-year blockbuster drug, a union claims in a federal antitrust class action.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.